1. Registered Address: Avillion LLP,111 BuckinghamPalaceRoad,London SW1W 0SR
Registered in England & Wales No: OC379058
To Whom It May Concern:
Re: Julia Upson
Background
Avillion is a drug development company with an innovative business model for the
clinical development and approval of late stage pharmaceutical products. It offers
a compelling opportunity to partner late phase therapeutic projects for approval in
the EU and US and to accelerate their availability to the market. We are staffed
with a team of expert professionals with extensive experience in the clinical
development and regulatory approval of pharmaceutical products on a global basis.
Our offices are in London, and we are financed by our international investors,
Abingworth, Clarus Ventures and Royalty Pharma.
Reference
Julia undertook a work placement for one week with Avillion in July 2015. During
her time with us she worked under Anna Danilewicz, Head of Clinical Operations
and her team, our Finance Department and CEO’s office. She undertook various
research assignments, a staff time analysis, planned, attended and produced
minutes of various clinical operations meetings. She received overview
presentations from each department including operations, quality assurance, and
finance and took part in a 1:1 discussion with our CEO.
Julia comes across a mature individual, professional, polite and courteous. She is
very focussed, was engaged and interested in everything she was involved with at
Avillion around clinical development. We were impressed with both her approach,
and the excellent work she produced.
Note from CEO
Julia is intelligent, articulate and showed initiative and enthusiasm during her time at
Avillion. She will be a great asset to any company in the future - we wish her every
success.
Dr Allison Jeynes-Ellis - Chief Executive
Should you have any questions, please contact Lisa Phillips, CEO’s Office, Avillion LLP on Tel: 0203 764 9531